Pete joined CONMED Corporation in 2015 and is responsible for all corporate strategy,
business development, M&A and acquisition integration activities for the company. In his
tenure to date, Pete has led acquisitions totaling over $1.2 Billion in transaction value for
CONMED. Prior to joining CONMED, Pete spent two years at Cardinal Health where he
oversaw the strategic investment and M&A ;pipeline as well as new business formation
efforts for the Medical Products Group within Cardinal Health’s Medical Segment. Prior to
joining Cardinal Health, Pete spent fifteen years as a venture capitalist, leading the
healthcare and life sciences investment effort at Baird Venture Partners in Chicago for
almost ten years and serving on the Boards of venture companies including Accuri
Cytometers (sold to Becton Dickinson), NimbelGen, Inc. (sold to Roche Holding AG) and
PharMEDium Healthcare Corporation (sold to Oak Investment Partners). Pete spent a
previous five years at Vector Fund Management, a life-sciences venture firm also based in
Chicago. Prior to his career in venture capital, Pete worked in corporate finance, mergers &
acquisitions and merchant banking at JP Morgan & Co. and Banc One Capital Corporation.
Pete was the founding Chair of AdvaMed’s National Venture Capital Advisory Board and a
founding Board member of the Mid-America Healthcare Investors Network (MHIN). Pete
received his undergraduate degree in Business Administration and Finance from Miami
University in Oxford, Ohio, and his MBA from the Amos Tuck School at Dartmouth.